FDA greenlights COVID-19 booster vaccine for some immunocompromised patients
The FDA authorized a COVID-19 booster shot for certain immunocompromised patients after evidence indicated a weak immune response following the initial two-dose series.
x
FDA greenlights COVID-19 booster vaccine for some immunocompromised patients
The FDA authorized a COVID-19 booster shot for certain immunocompromised patients after evidence indicated a weak immune response following the initial two-dose series.